News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

July 28, 2021

Sapphiros, a Next-Generation Diagnostics Platform, Announces Executive Appointments

MENLO PARK, Calif.–(BUSINESS WIRE)–Sapphiros, a KKR-backed platform building the next generation of diagnostic technologies, today announced the appointment of Mark Gladwell as Chief Operating Officer and Dr. Niall Armes as Chief Technology Officer. Mr. Gladwell and Dr. Armes will...

July 21, 2021

KKR partners with Namal Nawana to form Sapphiros, a next-generation diagnostics platform

MENLO PARK, Calif.–(BUSINESS WIRE)– KKR, a leading global investment firm, and Namal Nawana, the former CEO of both Smith & Nephew and Alere, today announced the formation of Sapphiros, a platform to build the next generation of diagnostic technologies....

April 20, 2021

Gates Foundation backs Biocrucible’s COVID-19 venture

Biocrucible Ltd at Granta Park in the Cambridge technology cluster has received funding from the Bill & Melinda Gates Foundation to explore rapid molecular testing options for COVID-19 and other pathogens, which could be used in the home or...